Medicine
Mulpleta 3 mg tablet
Mulpleta 3 mg tablet is a prescription medicine containing Lusutrombopag for oral use, marketed by Vancocin Italia, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store MULPLETA in the original package at 20°C to 25°C (68°F to 77°F)…
Key facts
- Active ingredient (INN)
- Lusutrombopag
- Brand
- Mulpleta
- Strength
- 3 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 1 dose pack
- Marketing authorisation holder
- Vancocin Italia
- Manufacturers
- Vancocin ItaliaEddingpharm (U. SShionogi
- Origin register
- US FDA, United States
- Storage
- Store MULPLETA in the original package at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B02BX07 Lusutrombopag
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 27 August 2018
- Identifiers
- RxCUI 2054989, 2054995DailyMed set ID a390aec3-6e77-45f8-95d3-d4b8c2eeee40, f9fd0cfd-717d-4a87-99bc-de7b38807e55, 3f6b72db-3abc-4169-9bee-8dc3078357e6NDC 84230-551, 59630-551, 85320-551Application NDA210923
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 dose pack in 1 carton / 7 tablet, film coated in 1 dose pack | 84230-551-07 | Vancocin Italia | 9 December 2025 |
| 1 dose pack in 1 carton / 7 tablet, film coated in 1 dose pack | 85320-551-07 | Eddingpharm (U. S | 24 November 2025 |
| 1 dose pack in 1 carton / 7 tablet, film coated in 1 dose pack | 59630-551-07 | Shionogi | 27 August 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Lusutrombopag is a prescription medicine indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure. It is available as tablets for oral use. MedsAcross supplies Lusutrombopag for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LusutrombopagFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Mulpleta prescribing information (Vancocin Italia) · U.S. National Library of Medicine, DailyMed
Need Mulpleta 3 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.